Pfs Partners, LLC Gossamer Bio, Inc. Transaction History
Pfs Partners, LLC
- $187 Billion
- Q4 2024
A detailed history of Pfs Partners, LLC transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Pfs Partners, LLC holds 63 shares of GOSS stock, worth $88. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63
Previous 128
50.78%
Holding current value
$88
Previous $127,000
55.12%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding GOSS
# of Institutions
116Shares Held
163MCall Options Held
821KPut Options Held
557K-
Octagon Capital Advisors LP New York, NY18.4MShares$25.7 Million3.68% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$25.3 Million1.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$14 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL8.81MShares$12.3 Million0.03% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$11.3 Million4.56% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $132M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...